Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 17, 2024 08:00 ET | Source: Myriad Genetics, Inc.

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

SALT LAKE CITY, July 17, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from its nationwide Cancer Risk...
August 22, 2023 09:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of...
April 04, 2023 08:00 ET | Source: iCAD, Inc.

ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments

NASHUA, N.H., April 04, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
October 07, 2015 04:08 ET | Source: Diet Doc Diet and Weight Loss

Diet Doc Acknowledges and Supports Breast Cancer Awareness Month by Providing Customized Diet Plans that Burn Excess Fat Leading to a Reduced Breast Cancer Risk While Leaving Patients Looking and Feeling Better than Ever Before

LOS ANGELES, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Over 33,000 American women will receive the devastating breast cancer diagnosis this year. And, while there are some risk factors that are out of their...
September 30, 2013 10:34 ET | Source: Genetic Technologies Group

CONTEMPORARY OBSTETRICS AND GYNECOLOGY OF DAYTON ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST

DAYTON, Ohio, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Contemporary Obstetrics & Gynecology, part of the Providence Medical Group, today announced the availability of the BREVAGen™ predictive risk...
September 16, 2013 10:08 ET | Source: Genetic Technologies Group

PEARL W. YEE, M.D. INC. OF SAN FRANCISCO ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST

SAN FRANCISCO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Pearl Yee, MD, FACOG and clinical professor at the University of California, San Francisco, is pleased to announce that her private practice, Pearl W....
August 26, 2013 13:06 ET | Source: Genetic Technologies Group

OB/GYN ASSOCIATES IN LEWISBURG, PA ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST

SUNBURY, PA., Aug. 26, 2013 (GLOBE NEWSWIRE) -- Russell Stankiewicz, MD, FACOG, CCD, NMCP, is pleased to announce that OB/GYN Associates of Lewisburg, P.C. in Lewisburg, PA is now offering the...
June 24, 2013 12:16 ET | Source: Genetic Technologies Group

THE HEWITT CENTER FOR BREAST WELLNESS AT GRIFFIN HOSPITAL IN DERBY, CT LAUNCHES HIGH-RISK PROGRAM INCLUDING STATE-OF-THE-ART BREAST CANCER SCREENING OPTIONS

DERBY, Conn., June 24, 2013 (GLOBE NEWSWIRE) -- Denise Barajas, MD, medical director at The Hewitt Center for Breast Wellness in Derby, CT, has launched a high-risk breast cancer program that includes...
April 15, 2013 12:06 ET | Source: Genetic Technologies Group

STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE

CHARLOTTE, N.C., April 15, 2013 (GLOBE NEWSWIRE) -- Phenogen Sciences, Inc. recently presented study results demonstrating that BREVAGen™, a first-in-class, scientifically-validated predictive...